[The clinico-hemodynamic effects of the antioxidant ceruloplasmin in IHD patients].
Ceruloplasmin- and placebo-treated CHD patients were studied for severity of angina pectoris, changes in central hemodynamics, exercise tolerance. It is shown that ceruloplasmin promoted an increase in exercise tolerance, higher quality of life, arrest of the disease progress. Combined treatment of CHD incorporating ceruloplasmin produced a positive effect on central hemodynamics and contractile, pump capacities of the myocardium.
Zakirova
A N
AN
D000787:Angina Pectoris / Q000188:drug therapy / Q000503:physiopathology; D000789:Angina, Unstable / Q000188:drug therapy / Q000503:physiopathology; D000975:Antioxidants / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000627:therapeutic use; D002570:Ceruloplasmin / Q000627:therapeutic use*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000503:physiopathology*
D000975:Antioxidants; D002316:Cardiotonic Agents; D002570:Ceruloplasmin
Kliniko-gemodinamicheskie éffekty antioksidanta tseruloplazmina u bol'nykh IBS.